1h Free Analyst Time
The antigen market is forecasted to grow by USD 629.3 million during 2024-2029, accelerating at a CAGR of 8% during the forecast period. The report on the antigen market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.Speak directly to the analyst to clarify any post sales queries you may have.
The report offers an up-to-date analysis regarding the current market scenario, the latest trends and drivers, and the overall market environment. The market is driven by increasing global burden of infectious and chronic diseases, pivotal technological advancements in antigen production and design, and heightened global focus on vaccine development and pandemic preparedness.
The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market size data, segment with regional analysis and vendor landscape in addition to an analysis of the key companies. Reports have historic and forecast data.
The antigen market is segmented as below:
By Type
- Viral antigens
- Bacterial antigens
- Others
By Application
- Medical diagnostic
- Vaccine development
- Others
By End-user
- Manufacturers
- Diagnostic centers
- Hospitals
- Research institutes
By Geographical Landscape
- North America
- Europe
- Asia
- Rest of World (ROW)
The report on the antigen market covers the following areas:
- Antigen Market sizing
- Antigen Market forecast
- Antigen Market industry analysis
The report presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive primary and secondary research. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast accurate market growth.
Table of Contents
1 Executive Summary
2 Market Analysis
3 Market Landscape
4 Market Sizing
5 Historic Market Size
6 Five Forces Analysis
7 Market Segmentation by Type
8 Market Segmentation by Application
9 Market Segmentation by End-user
10 Customer Landscape
11 Geographic Landscape
12 Drivers, Challenges, and Opportunity/Restraints
13 Competitive Landscape
14 Competitive Analysis
15 Appendix
List of Exhibits
Executive Summary
The following companies are recognized as the key players in the global antigen market: ACROBIOSYSTEMS INC., Agilent Technologies Inc., BioMerieux SA, Bio Rad Laboratories Inc., Bio Techne Corp., Creative Diagnostics, Danaher Corp., DiaSorin SpA, Fapon Biotech, GenScript Biotech Corp., Hologic Inc., LGC Clinical Diagnostics, Merck KGaA, Microbix Biosystems Inc, RayBiotech Life Inc., Sd Biosensor Inc., Siemens Healthineers AG, Sino Biological Inc., Sysmex Corp., and Thermo Fisher Scientific Inc..Commenting on the report, an analyst from the research team said: "The latest trend gaining momentum in the market is shifting role of antigens in era of nucleic acid platforms."
According to the report, one of the major drivers for this market is the increasing global burden of infectious and chronic diseases.
The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to a SWOT analysis of the key vendors.
Companies Mentioned (Partial List)
A selection of companies mentioned in this report includes, but is not limited to:
- ACROBIOSYSTEMS INC.
- Agilent Technologies Inc.
- BioMerieux SA
- Bio Rad Laboratories Inc.
- Bio Techne Corp.
- Creative Diagnostics
- Danaher Corp.
- DiaSorin SpA
- Fapon Biotech
- GenScript Biotech Corp.
- Hologic Inc.
- LGC Clinical Diagnostics
- Merck KGaA
- Microbix Biosystems Inc
- RayBiotech Life Inc.
- Sd Biosensor Inc.
- Siemens Healthineers AG
- Sino Biological Inc.
- Sysmex Corp.
- Thermo Fisher Scientific Inc.
